Logo
Give a Missed Call
+91 99532 12345
Logo
Give a Missed Call
+91 99532 12345
Login

Home

smallArrow

Stocks Screener

smallArrow

Medicamen Biotech Share Price

Medicamen Biotech Share Price

Medicamen Biotech (INR)513.3-31   (-5.7%)

Exchange ScripsBSE531146NSEMEDICAMEQISININE646B01010

Stock Performance
Fundamentals
Technicals
Shareholding Patterns
Financials
Similar Stocks

Trendline of performance -

Medicamen Biotech Performance

Market performance
Open price540.6
High545.6
Volumes29807
Prev Close513.3
Low508.6
Closing date2024-10-21
Historical performance
1 Year High729.60
3 Year High1225.00
5 Year High1225.00
1 Year Low355.45
3 Year Low355.45
5 Year Low355.45

Medicamen Biotech Fundamentals

Company Valuation
Market Cap
Market Cap (₹Cr)
652
Face Value
Face Value (₹)
10
P/E Ratio
P/E Ratio
68.74
Dividend Yield
Dividend Yield
N/A

Medicamen Biotech Investment Returns

1 Year
-14.8%
3 Years
N/A
5 Years
N/A
10 Years
N/A

Medicamen Biotech Technicals

IndicatorsValueSignal
5-DMA530.6Bearish
10-DMA546Bearish
20-DMA542.4Bearish
50-DMA471.68Bullish
100-DMA468.1Bullish
200-DMA481.61Bullish

Shareholding Pattern

FieldSep-2024Jun-2024Mar-2024Dec-2023Sep-2023
Promoters11122
Foreign Investors---------------
Domestic Investors11122
Public Investors107911065110638102509417
Government---------------

Medicamen Biotech Financials

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Other Income2325178
Operating Profit258268258204
Interest57341915
Depreciation71645825
Profit Before Tax131170181164
Consolidated Net Profit95147149121
Adjusted EPS7121210

Balance Sheet

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Share Capital127127122122
Total Reserves1943178213431207
Minority Interest------------
Total Non-Current Liabilities576078
Total Liabilities2920276622521940
Capital Work in Progress------------
Total Assets2920276622521940

Cash Flow

Below figures are in Rs. Crores

ParticularsMar-2024Mar-2023Mar-2022Mar-2021
Cash Flow from Operating Activities-67-6341128
Cash Flow from Investing Activities-56-59-85-178
Cash Flow from Financing Activitie632914358
Net Cash Inflow / Outflow-60170-18
0%
Negative
Neutral
Positive
  • The stock has a PE ratio of 68.74.
  • 3Y Stock Price CAGR of the stock is -2.4.
  • The stock has a beta of 1.3.
  • In the last financial year, the company had an EBITDA of ₹258 Million.
  • The company generated revenue of ₹1793 Million in the previous financial year.

Medicamen Biotech

513.3-31   (-5.7%)

Investment Amount: ₹ 57090
Current Value: ₹ 51330
Performence: -10.1%
P/L: ₹ -5760
Top Gainers
SymbolChange%
VHL5303.9(20%)
GFLLIMITED119.34(20%)
DIFFNKG408.3(20%)
SILINV877.1(20%)
PILANIINVS7536.05(20%)
Top Losers
SymbolChange%
PNCINFRA366.8(-20%)
INDIAMART2508.6(-17%)
RBLBANK176.14(-14%)
WABAG1710(-9%)
JMFINANCIL147.05(-7%)
MITCON107.19(-7%)
TATACONSUM1017.05(-7%)
AETHER862.6(-7%)
Similar stocks

Strides Pharma Scien

▲ 27.4

1638.55

September 21 - October 21

RPG Life Sciences

▲ 22.3

2749.85

September 21 - October 21

Jagsonpal Pharma

▲ 18.8

487.3

September 21 - October 21

Unichem Lab

▲ 17.3

757.95

September 21 - October 21

Windlas Biotech

▲ 14

1002.95

September 21 - October 21

Ipca Laboratories

▲ 12.5

1614.35

September 21 - October 21

Gufic Biosciences

▲ 10.9

450.15

September 21 - October 21

Solara Active Pharma

▲ 9.7

822.35

September 21 - October 21

Announcing Stock of the Month!

Stock of the Month
Stock of the Month